This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Immunex Corporation. Active years: 2003-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2007
Title: Innovations in Autoimmunity: The Contributions of Mary K Kennedy
Introduction
Mary K Kennedy is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of immunology. With an impressive record of three patents, Kennedy's work primarily focuses on developing innovative methodologies for treating autoimmune and chronic inflammatory conditions. Her inventions play a crucial role in enhancing treatment options for patients suffering from these challenging diseases.
Latest Patents
Kennedy's latest patents detail methods for treating autoimmune and chronic inflammatory conditions utilizing antagonists of CD30 or CD30L. These inventions provide groundbreaking approaches by administering agents that hinder the CD30/CD30L interaction, which is essential in the progression of various autoimmune conditions. Moreover, her patents include combination treatments and strategies for addressing diseases resistant to traditional TNFα inhibitors. This involves administering agents capable of interrupting signal transduction pathways mediated by CD30 or IL-1. Additionally, her work outlines concurrent treatments that block both the CD30/CD30L interaction and the IL-4/IL-4R interaction. Kennedy has also developed an animal model aimed at screening potential agents for their effectiveness against conditions that show resistance to treatment.
Career Highlights
Mary K Kennedy has made a substantial impact on the medical field through her association with Immunex Corporation, a well-known company specializing in biopharmaceuticals. Her career is marked by her dedication to advancing therapies for autoimmune disorders, providing hope to countless individuals battling these illnesses.
Collaborations
Throughout her career, Kennedy has collaborated with esteemed professionals, including Kendall M Mohler and Dauphine S Barone. These partnerships have contributed to the richness of her research and the implementation of her patented methods in real-world applications.
Conclusion
Mary K Kennedy's innovative approaches to treating autoimmune and chronic inflammatory conditions illustrate her commitment to improving patient outcomes and advancing medical science. Through her patents and collaborations, she continues to pave the way for new treatment options in the field of immunology, demonstrating the crucial role inventors play in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile